REAL-LIFE COMPARISON OF DASATINIB AND NILOTINIB AS SECOND-LINE THERAPY AFTER IMATINIB FAILURE FOR CHRONIC PHASE CML

被引：0

作者：

Tiribelli, M. ^{[1
]}

Bonifacio, M. ^{[2
]}

Binotto, G. ^{[3
]}

Iurlo, A. ^{[4
,5
]}

Cibien, F. ^{[6
]}

Maino, E. ^{[7
]}

Guella, A. ^{[8
]}

Festini, G. ^{[9
]}

Minotto, C. ^{[10
]}

De Biasi, E. ^{[11
]}

De Marchi, F. ^{[12
]}

Scaffidi, L. ^{[2
]}

Frison, L. ^{[13
]}

Bucelli, C. ^{[4
,5
]}

Medeot, M. ^{[1
]}

Calistri, E. ^{[14
]}

Sancetta, R. ^{[7
]}

Stulle, M. ^{[9
]}

Krampera, M. ^{[2
]}

Gherlinzoni, F. ^{[15
]}

Semenzato, G. ^{[3
]}

Ambrosetti, A. ^{[2
]}

Fanin, R. ^{[1
]}

机构：

[1] Azienda Osped Univ Udine, Div Hematol & BMT, Udine, Italy

[2] Univ Verona, Sect Hematol, Dept Med, Verona, Italy

[3] Univ Padua, Hematol Sect, Dept Med, Sch Med, Padua, Italy

[4] IRCCS Ca Granda Maggiore Policlin Hosp Fdn, Oncohematol Div, Milan, Italy

[5] Univ Milan, Milan, Italy

[6] Ca Foncello Hosp, Hematol Unit, Treviso, Italy

[7] DellAngelo Hosp, Hematol Unit, Venice, Italy

[8] Santa Chiara Hosp, Hematol Unit, Trento, Italy

[9] AOU Ospedali Riuniti, Div Clin Hematol, Trieste, Italy

[10] ULSS 13, Dept Med Special, Oncol & Oncohematol Unit, Venice, Italy

[11] P Cosma Hosp, Hematol Unit, Padua, Italy

[12] Azienda Osped Univ Udine, Div Hematol & BMT, Udine, Italy

[13] HemPadua Univ, Sch Med, Dept Med, Dept Med,Hematol Sect, Padua, Italy

[14] Ca Foncello Hosp, Hematol Unit, Treviso, Italy

[15] Ca Foncello Hosp, Hematol Unit, Treviso, Italy

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P612

引用

页码：237 / 238

页数：2

共 50 条

[21] Bosutinib (BOS) as third-line therapy for chronic phase (CP) chronic myeloid leukemia (CML) following failure with imatinib (IM) and dasatinib (DAS) or nilotinib (NIL) [J].

Brummendorf, T. H. ;

Cortes, J. E. ;

Kantarjian, H. ;

Gambacorti-Passerini, C. ;

Baccarani, M. ;

Kim, D. ;

Zaritskey, A. ;

Navarro, J. ;

Rapoport, A. ;

Dorlhiac-Llacer, P. E. ;

Milone, J. ;

Zanichelli, M. ;

Besson, N. ;

Leip, E. ;

Kelly, V. ;

Khoury, H. J. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[22] Real-Life Analysis of Dasatinib in Chronic Phase CML Patients Aged > 60 Years Resistant/Intolerant to Imatinib [J].

Latagliata, Roberto ;

Breccia, Massimo ;

Stagno, Fabio ;

Luciano, Luigiana ;

Gozzini, Antonella ;

Castagnetti, Fausto ;

Annunziata, Mario ;

De Matteis, Silvia ;

Albano, Francesco ;

Ulisciani, Stefano ;

Pregno, Patrizia ;

Porrini, Raffaele ;

Abruzzese, Elisabetta ;

Martino, Bruno ;

Tiribelli, Mario ;

Musto, Pellegrino ;

Avanzini, Paolo ;

Rossi, Antonella Russo ;

Sica, Simona ;

Vitolo, Umberto ;

Montefusco, Enrico ;

Cambrin, Giovanna Rege ;

Ferrara, Felicetto ;

Rosti, Gianantonio ;

Santini, Valeria ;

Pane, Fabrizio ;

Di Raimondo, Francesco ;

Alimena, Giuliana .

BLOOD, 2009, 114 (22) :871-871

[23] Efficacy of nilotinib in a patient in late chronic phase CML, intolerant to imatinib and resistant to dasatinib [J].

Usala, Emilio .

CLINICAL MANAGEMENT ISSUES, 2011, 5 :27-30

[24] Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy [J].

F J Giles ;

E Abruzzese ;

G Rosti ;

D-W Kim ;

R Bhatia ;

A Bosly ;

S Goldberg ;

G L S Kam ;

M Jagasia ;

W Mendrek ;

T Fischer ;

T Facon ;

U Dünzinger ;

D Marin ;

M C Mueller ;

Y Shou ;

N J Gallagher ;

R A Larson ;

F-X Mahon ;

M Baccarani ;

J Cortes ;

H M Kantarjian .

Leukemia, 2010, 24 :1299-1301

[25] Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy [J].

Giles, F. J. ;

Abruzzese, E. ;

Rosti, G. ;

Kim, D-W ;

Bhatia, R. ;

Bosly, A. ;

Goldberg, S. ;

Kam, G. L. S. ;

Jagasia, M. ;

Mendrek, W. ;

Fischer, T. ;

Facon, T. ;

Duenzinger, U. ;

Marin, D. ;

Mueller, M. C. ;

Shou, Y. ;

Gallagher, N. J. ;

Larson, R. A. ;

Mahon, F-X ;

Baccarani, M. ;

Cortes, J. ;

Kantarjian, H. M. .

LEUKEMIA, 2010, 24 (07) :1299-1301

[26] Nilotinib therapy after dasatinib failure in patients with imatinib-resistant or -intolerant chronic myeloid leukemia (CML) in chronic phase (CP), accelerated phase (AP) or blast crisis (BC) [J].

Giles, Francis J. ;

le Coutre, Phillip ;

Bhalla, Kapil N. ;

Ossenkoppele, Gert ;

Alimena, Giuliana ;

Haque, Ariful ;

Gallagher, Neil ;

Kantarjian, Hagop M. .

BLOOD, 2007, 110 (11) :311A-312A

[27] Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice [J].

Breccia, Massimo ;

Abruzzese, Elisabetta ;

Castagnetti, Fausto ;

Bonifacio, Massimiliano ;

Gangemi, Domenica ;

Sora, Federica ;

Iurlo, Alessandra ;

Luciano, Luigiana ;

Gozzini, Antonella ;

Gentile, Massimo ;

Bocchia, Monica ;

Luzi, Debora ;

Maggi, Alessandro ;

Sgherza, Nicola ;

Isidori, Alessandro ;

Crugnola, Monica ;

Pregno, Patrizia ;

Scortechini, Anna Rita ;

Capodanno, Isabella ;

Pizzuti, Michele ;

Foa, Robin .

ANNALS OF HEMATOLOGY, 2018, 97 (09) :1577-1580

[28] Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice [J].

Massimo Breccia ;

Elisabetta Abruzzese ;

Fausto Castagnetti ;

Massimiliano Bonifacio ;

Domenica Gangemi ;

Federica Sorà ;

Alessandra Iurlo ;

Luigiana Luciano ;

Antonella Gozzini ;

Massimo Gentile ;

Monica Bocchia ;

Debora Luzi ;

Alessandro Maggi ;

Nicola Sgherza ;

Alessandro Isidori ;

Monica Crugnola ;

Patrizia Pregno ;

Anna Rita Scortechini ;

Isabella Capodanno ;

Michele Pizzuti ;

Robin Foà .

Annals of Hematology, 2018, 97 :1577-1580

[29] Hematologic and molecular response with dasatinib as second-line treatment in chronic myeloid leukemia (CML) with treatment failure [J].

Enrique Santos-Macias, Juan ;

Baez de la Fuente, Enrique ;

Salas-Delgado, Arnoldo .

GACETA MEDICA DE MEXICO, 2016, 152 (03) :334-338

[30] Propensity Score Matched Comparison of Dasatinib and Nilotinib As a Frontline Therapy in Newly Diagnosed CML with Chronic Phase [J].

Takahashi, Koichi ;

Kantarjian, Hagop M. ;

Jain, Preetesh ;

Jabbour, Elias ;

Wierda, William ;

Pemmaraju, Naveen ;

Ferrajoli, Alessandra ;

Dellasala, Sara E. ;

Pierce, Sherry ;

Verstovsek, Srdan ;

Ravandi, Farhad ;

O'Brien, Susan ;

Cortes, Jorge E. .

BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →